ClinVar Miner

Submissions for variant NM_018489.3(ASH1L):c.4289G>T (p.Gly1430Val)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV002471717 SCV002769209 likely pathogenic Intellectual disability, autosomal dominant 52 2020-05-21 criteria provided, single submitter clinical testing A heterozygous missense variant was identified, NM_018489.2(ASH1L):c.4289G>T in exon 3 of the ASH1L gene. This substitution is predicted to create a major amino acid change from a glycine to a valine at position 1430 of the protein; NP_060959.2(ASH1L):p.(Gly1430Val). The glycine at this position has high conservation (100 vertebrates, UCSC), but is not situated in a known functional domain (NCBI, PDB). In silico software predictions of the pathogenicity of this variant are conflicting (PolyPhen2, SIFT, CADD, Mutation Taster). The variant is not present in the gnomAD population database. This variant has not previously been reported in clinical cases. Testing of this patient's parents has confirmed this variant is de novo. Based on information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.